Skip to main content
logo
Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
29.20
-1.05 (-3.47%)
Mar 3, 2026, 4:00 PM EST - Market closed

Alkermes Revenue

Alkermes had revenue of $394.19M in the quarter ending September 30, 2025, with 4.24% growth. This brings the company's revenue in the last twelve months to $1.09B, down -29.94% year-over-year. In the year 2024, Alkermes had annual revenue of $1.56B, down -6.36%.

Revenue (ttm)
$1.09B
Revenue Growth
-29.94%
P/S Ratio
3.30
Revenue / Employee
$719,951
Employees
2,050
Market Cap
4.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.56B-105.77M-6.36%
Dec 31, 20231.66B551.61M49.61%
Dec 31, 20221.11B-61.96M-5.28%
Dec 31, 20211.17B135.00M13.00%
Dec 31, 20201.04B-55.52M-5.07%
Dec 31, 20181.09B348.58M46.75%
Dec 31, 2016745.69M117.36M18.68%
Dec 31, 2015628.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bausch Health Companies10.27B
Dr. Reddy's Laboratories3.85B
Amneal Pharmaceuticals3.02B
Hims & Hers Health2.35B
Lantheus Holdings1.54B
Phibro Animal Health1.46B
Prestige Consumer Healthcare1.10B
BioCryst Pharmaceuticals874.84M
Revenue Rankings

ALKS News

More News